Literature DB >> 8008760

Malaria parasites undergo antigenic variation at high rates in vivo.

L R Brannan1, C M Turner, R S Phillips.   

Abstract

The rates of switching between expression of variable antigen types (VATS) have been investigated in vivo in a cloned line of Plasmodium chabaudi chabaudi. VAT-specific hyperimmune sera combined with an immunogold-silver staining technique were used to detect VATS, and five estimates of VAT-specific switching rates were determined for three of them. VAT-specific switching rates were consistent for each VAT and differed between VATS in the range 1.3 x 10(-2) to 4.3 x 10(-4) switches per schizont per generation. This variation suggests that hierarchical expression of VATS in an infection may be determined by switch rates. A minimum estimate of the overall switching rate was determined by summation of the VAT-specific rates in each of two experiments. In both cases the results showed that at least 1 in every 80 schizonts switched VAT expression every generation. This is the first report of antigenic switching rates for malaria parasites measured in vivo in the presence of minimal specific immune pressure, and is the first to show that VAT-specific switching rates vary between VATS. We conclude that switching is rapid and spontaneous, and is regulated, at least in part, by the VATS involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008760     DOI: 10.1098/rspb.1994.0051

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  16 in total

1.  Selection for high and low virulence in the malaria parasite Plasmodium chabaudi.

Authors:  M J Mackinnon; A F Read
Journal:  Proc Biol Sci       Date:  1999-04-07       Impact factor: 5.349

2.  Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice.

Authors:  Sandra Cheesman; Ahmed Raza; Richard Carter
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Variable var transition rates underlie antigenic variation in malaria.

Authors:  Paul Horrocks; Robert Pinches; Zóe Christodoulou; Sue A Kyes; Chris I Newbold
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

4.  Can mutation and selection explain virulence in human P. falciparum infections?

Authors:  Ian M Hastings; S Paget-McNicol; A Saul
Journal:  Malar J       Date:  2004-03-02       Impact factor: 2.979

5.  Cross-reactive immune responses as primary drivers of malaria chronicity.

Authors:  Eili Y Klein; Andrea L Graham; Manuel Llinás; Simon Levin
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

6.  Variant antigens and endothelial receptor adhesion in Plasmodium falciparum.

Authors:  J P Gardner; R A Pinches; D J Roberts; C I Newbold
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  A large gene family for putative variant antigens shared by human and rodent malaria parasites.

Authors:  Christoph S Janssen; Michael P Barrett; C Michael R Turner; R Stephen Phillips
Journal:  Proc Biol Sci       Date:  2002-02-22       Impact factor: 5.349

8.  Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues.

Authors:  P Sharma; A Kumar; B Singh; A Bharadwaj; V N Sailaja; T Adak; A Kushwaha; P Malhotra; V S Chauhan
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

9.  High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers.

Authors:  Jennifer Peters; Elizabeth Fowler; Michelle Gatton; Nanhua Chen; Allan Saul; Qin Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-25       Impact factor: 11.205

Review 10.  Virulence in malaria: an evolutionary viewpoint.

Authors:  Margaret J Mackinnon; Andrew F Read
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.